NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy.
Guillermo Montalban-Bravo,Rashmi Kanagal-Shamanna,Koji Sasaki,Keyur Patel,Irene Ganan-Gomez, Elias Jabbour,Tapan Kadia,Farhad Ravandi,Courtney DiNardo,Gautham Borthakur,Koichi Takahashi,Marina Konopleva,Rami S Komrokji,Amy DeZern,Teodora Kuzmanovic,Jaroslaw Maciejewski,Sherry Pierce,Simona Colla,Mikkael A Sekeres,Hagop Kantarjian,Carlos Bueso-Ramos,Guillermo Garcia-Manero Blood advances（2019）
AI 理解论文
溯源树
样例
